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To elucidate the distribution and nature of EGF i n human body f l u i d s , we measured immunoreactive EGF (IR-EGF) by a RIA or a (more sensitive) time-resolved immunofluorometric assay, and evaluated i t s s i z e heterogeneity by s i z e exclusion high performance liquid chromatography. The mean concentration was 80nglml in urine, 65nglml i n milk, 50nglml i n seminal plasma, 25nglml i n armpit sweat, 1.0 nglml i n breast sweat, 3ng/ml i n s a l i v a , 1.5ngI m l i n tears, and 0.3nglml i n g a s t r i c juice and third trimester amniotic f l u i d . A l l the fluids contained the standard s i z e 6.2 kilodalton (6.2K) IR-EGF molecule. I t was the only component present i n armpit sweat and gastric juice. Additionally, we observed the t o t a l of 5 different molecular sizes of IR-EGF, ranging i n approximate molecular weight from 400K to 15K. The standard form made up '90% of the t o t a l IR-EGF i n a l l the fluids except the amniotic f l u i d , where i t s proportion was 71%. A >400K component was present i n milk and amniotic f l u i d , a 300K component i n urine and seminal plasma, a 200K component i n breast sweat, a 80K component i n seminal plasma, saliva and t e a r s and a 15K component i n urine, seminal plasma, and the amniotic f l u i d . I t remains t o be studied whether the larger than standard forms of IR-EGF represent different cleavage products of a common precursor, d i f f e r e n t tissue specific products, aggregates of EGF, EGF bound t o different proteins, or several of these. The apparent inability of elevated atrial-natriuretic peptide (ANP) levels to cause natriuresis and diuresis in children with heart failure may be related to a reduced response of target organs to ANP. The cellular effects of ANP seem to be mediated by cCMP a s the second messenger of ANP. Simultaneous measuremen of ANP and cGMP has been shown to be a useful tool to study the cellular response to ANP. Therefore, plasma ANP and cGMP levels were measured by radioimmonoassay in 168 healthy childrer and in 47 children with congenital cardiac diseases. In healthy children ANP and cGMP plasma levels were measured in the range of 5-109 pglml (mean 45.5) and 0.2-2.8 pmollml (mean 1.3) respectively. In children with cardiac diseases significantly higher ANP (range 30-980, mean 280 pglml) and cGMP levels (range 0.2-6.0, mean 2.8 pmollml) were determined. There was a highly significant correlation between the two in children with cardiac diseases (p<0.001). Furthermore, a significant correlation was found between right atrial pressure and ANP levels (p<0.01) suggesting that atrial stretch is a stimulus for ANP release. The positive correlation between ANP and cCMP levels disagrees with the hypothesis that the cellular response to ANP is diminished in children with cardiac diseases.
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i s l e t s in culture maintained for 3 days in serum f r e e medium. c o n c o m i t a n t r e d u c t i o n o f body w e i g h t .
In conclusion : IGF-I i s present in the r a t pancreas and in These o b s e r v a t i o n s s u g g e s t t h a t volume e x p a n s i o n i s a the medium of i s l e t s c e l l s in culture together with a binding p o t e n t s t i m u l u s o f ANP r e l e a s e i n c h i l d r e n a n d t h a t protein. Effect of GH on IGF-I production i n the medium seems t o t h i s hormone i s i m p o r t a n t i n volume h o m e o s t a s i s .
indicate t h a t GH multiplicatory a c t i v i t y on O-cell might be S u p p o r t e d b y D e u t s c h e F o r s c h u n g s g e m e i n s c h a f t Ra 326/1-2 mediated local IGF-I
